Redcare Pharmacy: scaling Rx and strengthening operating cash generation with adj. EBITDA margin of 2.4% in Q3.
Redcare Pharmacy N.V. / Key word(s): 9 Month figures
29.10.2025 / 06:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
29.10.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News
This news is powered by Ad Hoc News 
